Literature DB >> 23802573

Strategies to improve recovery in acute ischemic stroke patients: Iberoamerican Stroke Group Consensus.

M Alonso de Leciñana1, M Gutiérrez-Fernández, M Romano, C Cantú-Brito, A Arauz, L E Olmos, S F Ameriso, E Díez-Tejedor.   

Abstract

Stroke is not only a leading cause of death worldwide but also a main cause of disability. In developing countries, its burden is increasing as a consequence of a higher life expectancy. Whereas stroke mortality has decreased in developed countries, in Latin America, stroke mortality rates continue to rise as well as its socioeconomic dramatic consequences. Therefore, it is necessary to implement stroke care and surveillance programs to better describe the epidemiology of stroke in these countries in order to improve therapeutic strategies. Advances in the understanding of the pathogenic processes of brain ischemia have resulted in development of effective therapies during the acute phase. These include reperfusion therapies (both intravenous thrombolysis and interventional endovascular approaches) and treatment in stroke units that, through application of management protocols directed to maintain homeostasis and avoid complications, helps to exert effective brain protection that decreases further cerebral damage. Some drugs may enhance protection, and besides, there is increasing knowledge about brain plasticity and repair mechanisms that take place for longer periods beyond the acute phase. These mechanisms are responsible for recovery in certain patients and are the focus of basic and clinical research at present. This paper discusses recovery strategies that have demonstrated clinical effect, or that are promising and need further study. This rapidly evolving field needs to be carefully and critically evaluated so that investment in patient care is grounded on well-proven strategies.
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization.

Entities:  

Keywords:  brain plasticity; brain protection; brain repair; ischemic stroke

Mesh:

Substances:

Year:  2013        PMID: 23802573     DOI: 10.1111/ijs.12070

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  6 in total

Review 1.  Role of Exosomes as a Treatment and Potential Biomarker for Stroke.

Authors:  Laura Otero-Ortega; Fernando Laso-García; MariCarmen Gómez-de Frutos; Blanca Fuentes; Luke Diekhorst; Exuperio Díez-Tejedor; María Gutiérrez-Fernández
Journal:  Transl Stroke Res       Date:  2018-08-13       Impact factor: 6.829

Review 2.  Stem Cell Therapy and Administration Routes After Stroke.

Authors:  Berta Rodríguez-Frutos; Laura Otero-Ortega; María Gutiérrez-Fernández; Blanca Fuentes; Jaime Ramos-Cejudo; Exuperio Díez-Tejedor
Journal:  Transl Stroke Res       Date:  2016-07-07       Impact factor: 6.829

3.  Decreased plasma miR-335 expression in patients with acute ischemic stroke and its association with calmodulin expression.

Authors:  Bin Zhao; Zilong Zhu; Junwei Hao; Zongming Wan; Xiaoqin Guo
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

4.  Low dose of extracellular vesicles identified that promote recovery after ischemic stroke.

Authors:  Laura Otero-Ortega; Fernando Laso-García; Mari Carmen Gómez-de Frutos; Luke Diekhorst; Arturo Martínez-Arroyo; Elisa Alonso-López; María Laura García-Bermejo; Macarena Rodríguez-Serrano; Mercedes Arrúe-Gonzalo; Exuperio Díez-Tejedor; Blanca Fuentes; María Gutiérrez-Fernández
Journal:  Stem Cell Res Ther       Date:  2020-02-19       Impact factor: 6.832

5.  Total Flavonoids in Caragana (TFC) Promotes Angiogenesis and Enhances Cerebral Perfusion in a Rat Model of Ischemic Stroke.

Authors:  Qiansong He; Shirong Li; Lailai Li; Feiran Hu; Ning Weng; Xiaodi Fan; Shixiang Kuang
Journal:  Front Neurosci       Date:  2018-09-12       Impact factor: 4.677

6.  Association of serum vaspin, apelin, and visfatin levels and stroke risk in a Chinese case-control study.

Authors:  Dalin Yu; Bin Huang; Bin Wu; Jun Xiao
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.